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Objectives. The purpose of this study was to describe the long-
term follow-up results in 62 patients with atrial fibrillation and an
uncontrolled ventricular rate, who underwent radiofrequency
modification of the atrioventricular (AV) node.
Background. Previous studies in small numbers of patients
have suggested that radiofrequency modification may be effective
in controlling the ventricular rate in patients with atrial fibrilla-
tion, but long-term follow-up data have been lacking.
Methods. The subjects of this study were 62 consecutive pa-
tients (mean age 6 SD 65 6 14 years; 43 with structural heart
disease) who underwent an attempt at radiofrequency modifica-
tion of the AV node because of symptomatic, drug-refractory atrial
fibrillation with an uncontrolled ventricular rate. The atrial
fibrillation was chronic in 46 patients and paroxysmal in 16.
Radiofrequency energy was applied to the posteroseptal or mid-
septal right atrium to lower the ventricular rate in atrial fibrilla-
tion to 120 to 130 beats/min during an infusion of 4 mg/min of
isoproterenol.
Results. Short-term control of the ventricular rate was success-
fully achieved without the induction of pathologic AV block in 50
(81%) of 62 patients. Inadvertent high degree AV block occurred
in 10 (16%) of 62 patients, with the AV block occurring at the time
of the procedure in 6 patients and 36 to 72 h after the procedure
in 4. During 19 6 8 months of follow-up (range 4 to 33), 5 (10%)
of 50 patients had a symptomatic recurrence of an uncontrolled
rate during atrial fibrillation. Overall, adequate rate control at
rest and during exertion, without pathologic AV block, was
achieved long term in 45 (73%) of 62 patients. Among 37 patients
with a successful outcome, left ventricular ejection fraction in-
creased from (mean 6 SD) 0.44 6 0.14 to 0.51 6 0.10 one year
later (p < 0.001). Complications other than AV block included
polymorphic ventricular tachycardia 10 to 24 h after the proce-
dure in two patients who had a predisposing factor for ventricular
tachycardia and sudden death 1 to 5 months after the procedure
in two patients with idiopathic dilated cardiomyopathy, one of
whom had a pacemaker for AV block.
Conclusions. In ;70% of properly selected patients with atrial
fibrillation and an uncontrolled ventricular rate, radiofrequency
modification of the AV node results in excellent long-term control
of the ventricular rate at rest and during exertion.
(J Am Coll Cardiol 1997;27:113–21)
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Several studies (1–6) have demonstrated that it is feasible to
modify atrioventricular (AV) node conduction without creat-
ing pathologic AV block in patients with atrial fibrillation and
an uncontrolled ventricular rate using radiofrequency energy.
However, the number of patients in these studies has been
small, and the duration of follow-up has been relatively short.
Several important issues have remained unclear, including the
long-term changes in ventricular rate, the incidence of recur-
rence of rapid AV conduction, and the long-term effects on left
ventricular function. The purpose of this study was to clarify
these issues by describing the long-term follow-up in 62
patients with atrial fibrillation and an uncontrolled ventricular
rate who underwent radiofrequency modification of the AV
node to control the ventricular rate.
Methods
Patients. The subjects of this study were 62 consecutive
patients who underwent an attempt at radiofrequency modifi-
cation of the AV node at the University of Michigan Medical
Center because of symptomatic, drug-refractory atrial fibrilla-
tion with an uncontrolled ventricular rate. In selecting patients
to undergo this procedure, there were two exclusion criteria: 1)
symptomatic bradycardia or pauses $2 s, not attributable to
pharmacologic therapy; 2) the presence of symptoms at rest,
such as those due to irregularity, in association with a ventric-
ular rate during atrial fibrillation #90 beats/min. If one of
these exclusion criteria was present, the patient underwent
radiofrequency ablation of the AV junction and insertion of a
permanent pacemaker. During the time that the 62 patients in
this study were recruited, 17 other patients underwent ablation
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of the AV node because of the presence of one of these
exclusion criteria.
The clinical characteristics of the patient population are
described in Table 1. Atrial fibrillation was chronic in 46
patients and paroxysmal in 16. Mean left ventricular ejection
fraction determined by echocardiography or radionuclide ven-
triculography was 0.44 6 0.14 (mean 6 SD). Before the
electrophysiologic procedure, a mean of 4.5 6 1.3 antiarrhyth-
mic drugs had been ineffective in maintaining sinus rhythm or
controlling ventricular rate, including amiodarone in 24 pa-
tients. Every patient had symptoms of either palpitations or
decreased exercise tolerance, or both. Mean Canadian Cardio-
vascular Society functional class before the electrophysiologic
procedure was 3.0 6 0.6. Twenty of the 62 patients were the
subjects of two earlier reports and are included in the present
series to provide long-term follow-up data (3,7).
Characterization of ventricular rate. As described previ-
ously (3), the ventricular rate was characterized under the
following four conditions: 1) at rest, with the patient sitting; 2)
after walking 50 yards at the patient’s usual pace; 3) at peak
exercise during a symptom-limited exercise treadmill test,
except in patients in whom an exercise test was not feasible
because of severe symptoms; 4) during 24-h ambulatory mon-
itoring, to identify the slowest rate during atrial fibrillation.
Whenever possible, these rates were measured in the absence
of antiarrhythmic drug therapy, both before and after the
radiofrequency procedure. However, in 15 patients who were
being treated with digoxin, a beta-adrenergic antagonist or a
calcium channel antagonist for reasons other than rate control,
therapy with these agents was not discontinued.
Radiofrequency modification protocol. The study protocol
was approved by the Human Research Committee at the
University of Michigan. The technique has been described
previously (3). After written informed consent was obtained,
two quadripolar electrode catheters were positioned at the His
bundle and in the right ventricle using a femoral vein ap-
proach. The catheter used to deliver radiofrequency energy
was a 7F quadripolar electrode catheter with a 4-mm distal
electrode, 2–5–2-mm interelectrode spacing and a deflectable
tip (Mansfield Scientific or EP Technologies). Whenever nec-
essary, a 60-cm guiding sheath (Daig Corp) was used to
improve stability of the ablation catheter. Radiofrequency
energy at a frequency of 500 kHz (EP Technologies) was
delivered through the distal electrode of the ablation catheter.
A large patch electrode (Valleylab) on the posterior thorax
served as the indifferent electrode.
If the patient was in sinus rhythm at the onset of the
procedure, the baseline atrial–His (AH) and His–ventricular
(HV) intervals, the AV block cycle length and the AV node
effective refractory period were measured. Effective refractory
periods were determined at a basic drive cycle length of
600 ms. For the purpose of this study, if atrial refractoriness
limited the determination of the AV node effective refractory
period, the atrial effective refractory period was used as a
substitute for the AV node effective refractory period.
If necessary, atrial fibrillation was induced by rapid atrial
pacing. The ventricular rate during atrial fibrillation was
measured in the baseline state and during infusion of isopro-
terenol at a rate of 4 mg/min. Applications of radiofrequency
energy usually were delivered during the infusion of isoproter-
enol to allow immediate assessment of the effect of the
radiofrequency energy under conditions simulating exercise.
The ablation catheter was positioned in the posteroseptal
right atrium, at the level of the coronary sinus ostium, where
the AV electrogram ratio was #0.5. Radiofrequency energy
was delivered at an initial power setting of 12 W and slowly
titrated upward to a maximum of 50 W for 1 min, according to
temperature or impedance monitoring (8) and the response of
the ventricular rate. The application of radiofrequency energy
was immediately stopped whenever the RR interval abruptly
lengthened. If there was no change in the ventricular rate, the
catheter was positioned at progressively more superior and
anterior positions along the right atrial septum. No applica-
tions were delivered at sites where the His bundle amplitude
exceeded 0.02 mV (3). The end point of the procedure was a
ventricular rate of 120 to 130 beats/min during the infusion of
isoproterenol.
In eight patients who were in sinus rhythm at the onset of
the procedure, electrical cardioversion was performed after
completion of radiofrequency energy delivery, and the AH and
HV intervals, AV block cycle length and AV node effective
refractory period again were determined.
Follow-up evaluation. After the procedure, the patients
underwent continuous electrocardiographic (ECG) monitor-
Abbreviations and Acronyms
AH 5 atrial–His interval
AV 5 atrioventricular
ECG 5 electrocardiographic
HV 5 His–ventricular interval
Table 1. Clinical Characteristics of 62 Patients
Age (yr) 656 14
Range 34–86
Men/women 32/30
Type of atrial fibrillation
Chronic 46
Paroxysmal 16
Duration of symptoms (yr) 5.46 5.6
Type of heart disease
Coronary artery disease 16
Valvular 12
Idiopathic dilated cardiomyopathy 7
Hypertension 5
Hypertrophic cardiomyopathy 3
None 19
Left ventricular ejection fraction 0.446 0.14
Data are expressed as mean value 6 SD or number of patients, unless
otherwise indicated.
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ing on an inpatient basis for at least 2 days and up to 4 days if
transient high degree AV block had occurred during the
procedure. A symptom-limited exercise treadmill test and 24-h
ambulatory monitoring were performed 2 to 4 days after the
procedure. The patients were seen in an outpatient clinic at
intervals of 3, 12 and 24 months after the procedure, and a
symptom-limited exercise treadmill test and 24-h ambulatory
monitor recording were obtained at these times. Among the
patients with paroxysmal atrial fibrillation, at least one episode
of atrial fibrillation was documented by ambulatory monitoring
between 4 and 24 months of follow-up. Left ventricular
ejection fraction was measured by echocardiography or radio-
nuclide ventriculography 12 months after the procedure. All
patients have had at least 4 months of follow-up; 44 have had
$12 months of follow-up; and 21 have had at least 24 months
of follow-up.
Statistical analysis. Continuous variables are expressed as
mean value 6 SD and were compared using a paired t test or
by analysis of variance with repeated measures. Multiple
comparisons were performed using the Fisher least significant
difference technique. Categoric variables were compared by
contingency table analysis; p, 0.05 was considered significant.
Results
Effective control of ventricular rate. At the time of dis-
charge from the hospital 2 to 4 days after the radiofrequency
procedure, the ventricular rate was successfully controlled
without induction of pathologic AV block in 50 (81%) of the 62
patients. The mean number of applications of radiofrequency
energy was 12 6 8 (range 1 to 35), and the mean duration of
fluoroscopy was 31 6 17 min (range 8 to 75). The location of
the radiofrequency energy application that resulted in slowing
of the ventricular rate was posteroseptal in 15 patients and
midseptal in 35.
During a mean follow-up period of 19 6 8 months (range 4
to 33), 5 (10%) of the 50 patients had a symptomatic recur-
rence of an uncontrolled rate during atrial fibrillation; the
symptoms recurred in these patients between 2 and 9 weeks
after the procedure. Two of the five patients underwent a
second attempt at radiofrequency modification of the AV
node, which was effective long term. There were no identifiable
predictors of recurrence of a rapid rate after an initially
successful procedure.
Another 2 of the 50 patients, who underwent the procedure
because of paroxysmal atrial fibrillation, had a recurrence of
symptoms of palpitations and exercise intolerance 2 to 4 weeks
afterward and were found to have paroxysmal atrial flutter as
the cause of their symptoms. In these two patients, the
ventricular rate at rest during atrial fibrillation was 64 to 76
beats/min compared with 110 to 130 beats/min at rest during
atrial flutter.
Overall, adequate rate control without pathologic AV block
was achieved long term in 45 (73%) of 62 patients. The
long-term success rate was 76% among the 46 patients with
chronic atrial fibrillation compared with 62% among the 16
patients with paroxysmal atrial fibrillation (p 5 0.3).
Atrioventricular block. Inadvertent high degree AV block
occurred in 10 (16%) of the 62 patients, with the AV block
occurring at the time of the procedure in 6 patients and 36 to
72 h after the procedure in 4. The application of radiofre-
quency energy that resulted in high degree AV block was
posteroseptal in three patients and midseptal in seven. A His
bundle depolarization was absent at eight of these sites and
present but ,0.02 mV in amplitude at two of the sites. Each of
the four patients in whom the onset of high degree AV block
was delayed had transient third-degree AV block lasting 10 to
27 s during the initial procedure. Transient third-degree AV
block also occurred during the procedure in 16 patients who
had a successful outcome.
Each of the 10 patients who developed inadvertent high
degree AV block had a junctional escape rhythm at a rate of 40
to 58 beats/min and underwent implantation of a permanent
pacemaker.
Ablation of the AV junction and pacemaker implantation
were performed intentionally in 7 (11%) of the 62 patients: at
the time of the initial procedure in 2; after a recurrence of a
rapid ventricular rate during atrial fibrillation at 2 to 9 weeks of
follow-up in 3; and for episodes of paroxysmal atrial flutter that
began at 2 to 4 weeks of follow-up in 2.
Ventricular rate. The mean ventricular rates during atrial
fibrillation, at rest and during ambulation, measured before the
radiofrequency modification procedure and at 2 days and at 3,
12 and 24 months after the procedure in the 45 patients who
had a successful outcome are shown in Figures 1 and 2. The
mean maximal ventricular rates during exercise before the
Figure 1. Mean ventricular rate at rest and while awake during atrial
fibrillation, before and after radiofrequency modification of the AV
node. bpm 5 beats/minute. Vertical bars 5 SD; numbers in paren-
theses 5 number of patients in whom heart rate data were available.
*p , 0.001, significant difference versus baseline.
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procedure and at 2 days and 3, 12 and 24 months of follow-up
are shown in Figure 3. For each of the conditions under which
the ventricular rate was measured, there was a significant
decrease compared with baseline values throughout the period
of follow-up. There were no significant changes in rate at 2
days and 24 months of follow-up, except in the case of the
maximal rate, which was significantly greater at 12 and 24
months than at 2 days of follow-up.
Atrioventricular node properties. Atrioventricular node
properties were measured before and after a successful radio-
frequency modification procedure in eight patients. The mean
AH interval, AV block cycle length and AV node effective
refractory period were significantly prolonged by the proce-
dure (Table 2). Dual-AV node physiology was present in two
patients before the procedure and in no patient afterward.
Symptoms and functional class. Among the 45 patients in
whom the ventricular rate was controlled long term after the
radiofrequency modification procedure, 33 (82%) of 40 with a
history of palpitations reported that the palpitations had
resolved or were infrequent and mild, and the remaining 7
patients (18%) described the palpitations as improved and
tolerable, but present every day. Among the 17 patients who
underwent pacemaker implantation because of third-degree
AV block, 13 (87%) of 15 with a history of palpitations
reported resolution of symptoms during long-term follow-up,
and the other 2 described persistent palpitations as mild. The
percentage of patients who reported resolution of palpitations
did not differ significantly between the two groups of patients
(p 5 0.7).
The mean Canadian Cardiovascular Society functional class
improved from 3.06 0.5 to 1.66 0.5 (p, 0.001) among the 45
patients with a successful outcome from the radiofrequency
modification procedure. Among the 17 patients who received a
pacemaker, the mean functional class improved from 3.1 6 0.5
to 1.5 6 0.4 (p , 0.001). The degree of improvement in
functional class did not differ significantly between the patients
in whom the radiofrequency modification procedure was suc-
cessful and those who received a pacemaker (p 5 0.9).
Complications other than AV block. Two patients (3%)
had documented episodes of polymorphic ventricular tachycar-
dia 10 to 24 h after the radiofrequency modification procedure.
One patient, a 69-year old woman with dilated, nonischemic
cardiomyopathy who was the subject of an earlier report (7),
developed sustained polymorphic ventricular tachycardia as a
complication of amiodarone therapy 5 days before the modi-
fication procedure and had a recurrence 10 h after the
procedure, when the average ventricular rate during atrial
Figure 2. Mean ventricular rate during atrial fibrillation after walking
50 yards, before and after radiofrequency modification of the AV
node. bpm 5 beats/minute. Format as in Figure 1. *p , 0.001, sig-
nificant difference versus baseline.
Figure 3. Mean ventricular rate during atrial fibrillation at peak
exercise on a treadmill, before and after radiofrequency modification
of the AV node. bpm 5 beats/minute. Format as in Figure 1. *p ,
0.001, significant difference versus baseline. #p , 0.05, significant
change at 12 and 24 months versus 2 days of follow-up.
Table 2. Atrioventricular Node Properties and His–Ventricular
Interval Before and After Radiofrequency Modification in
Eight Patients
Before RF
Modification
After RF
Modification
p
Value
Sinus cycle length (ms) 7426 98 732 6 90 0.1
Atrial–His interval (ms) 866 14 123 6 28 , 0.01
His–ventricular interval (ms) 456 5 45 6 5 1.0
AVN block cycle length (ms) 3356 28 432 6 64 , 0.01
AVN ERP (ms) 2756 29 369 6 70 , 0.01
Dual AVN physiology 2/8 (25%) 0/8 0.4
Data are expressed as mean value 6 SD or number (%) of patients. AVN 5
atrioventricular node; ERP 5 effective refractory period; RF 5 radiofrequency.
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fibrillation was 70 beats/min and the corrected QT interval was
570 ms. The other patient was a 62-year old woman with
moderately severe aortic and mitral stenosis and a left ventric-
ular ejection fraction of 0.50 who experienced syncope in
association with a 30-s episode of polymorphic ventricular
tachycardia 24 h after the procedure, when the average ven-
tricular rate during atrial fibrillation was 70 beats/min and the
corrected QT interval was 560 ms (Fig. 4). The serum potas-
sium concentration was 3.8 mEq/liter shortly after the episode
of ventricular tachycardia. In both patients, a pacemaker was
implanted, and ventricular tachycardia did not recur during 3
months of pacing at a rate of 80 to 90 beats/min. The pacing
rate was then lowered to 60 beats/min, with no episodes of
symptomatic ventricular tachycardia during 11 to 22 months of
follow-up.
Two other patients (3%) died suddenly 1 to 5 months after
the procedure. Both were men, 52 and 71 years old, and both
had idiopathic dilated cardiomyopathy and a left ventricular
ejection fraction of 0.20. One patient had developed third-
degree AV block as a complication of the modification proce-
Figure 4. Example of polymorphic
ventricular tachycardia (VT) after
radiofrequency modification in a
patient who had a predisposing
factor for torsade de pointes. A,
ECG recorded 18 h after the mod-
ification procedure. The average
ventricular rate is 56 beats/min.
The corrected QT interval was
560 ms. The QT prolongation was
not recognized. B, Twenty-four
hours after the procedure, the pa-
tient developed ventricular bigem-
iny and a 30-s episode of polymor-
phic VT consistent with torsade de
pointes. The VT had a cycle length
of 170 to 200 ms and was accom-
panied by transient loss of con-
sciousness. The serum potassium
concentration measured immedi-
ately after the episode of VT was
3.8 mEq/liter. Polymorphic VT did
not recur after administration of
potassium chloride and the institu-
tion of ventricular pacing at a rate
of 85 beats/min.
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dure, underwent pacemaker implantation, was discharged
from the hospital with the pacemaker programmed in a VVIR
mode with rates of 70 to 120 beats/min and died suddenly 1
month later. In the other patient, the ventricular rate during
atrial fibrillation was successfully controlled by the radiofre-
quency modification procedure, but the patient died suddenly
5 months later. Neither patient underwent a postmortem
examination.
Two patients died of preexisting end-stage pulmonary hy-
pertension or chronic renal failure 1 to 2 weeks after the
radiofrequency modification procedure.
Left ventricular function. Among 50 patients in whom left
ventricular ejection fraction was measured before and 1 year
after the radiofrequency modification procedure, mean ejec-
tion fraction increased from 0.45 6 0.13 to 0.50 6 0.11 (p 5
0.001). In 37 of these patients who had a successful outcome,
left ventricular ejection fraction increased from 0.44 6 0.14 to
0.51 6 0.10 (p , 0.001), and in 13 patients with third-degree
AV block and a pacemaker, the baseline mean ejection
fraction of 0.47 6 0.12 remained unchanged at 0.46 6 0.13
(p 5 0.3).
Within the group of patients with a successful outcome,
there were 17 patients in whom baseline left ventricular
ejection fraction was ,0.50 and in whom a repeat determina-
tion of ejection fraction was available 1 year after the proce-
dure. The mean ejection fraction of 0.32 6 0.10 in this
subgroup of patients increased significantly to 0.436 0.10 (p,
0.01) (Fig. 5). Among the seven patients in this study who had
dilated nonischemic cardiomyopathy, measurement of left
ventricular ejection fraction at baseline and 1 year after the
modification procedure was available in four; in these four
patients, mean ejection fraction increased from 0.22 6 0.10 to
0.48 6 0.12 (p 5 0.02) (Fig. 5).
Among the patients who required a pacemaker, there were
six patients in whom baseline left ventricular ejection fraction
was ,0.50 and in whom a repeat determination of ejection
fraction was available 1 year after the procedure. Baseline
ejection fraction in these patients was 0.33 6 0.06 before
ablation and 0.33 6 0.08 1 year after ablation (p 5 0.7).
Discussion
Main findings. The results of this study indicate that in
patients with atrial fibrillation and a rapid ventricular rate,
adequate rate control without the need for a permanent
pacemaker can be achieved long term in ;70% of patients.
Although the short-term success rate was ;80%, there was a
10% recurrence rate of rapid AV conduction in the first 3
months after the procedure. An important limitation of the
radiofrequency modification technique used in this study was a
16% incidence of unintentional third-degree AV block. Other
potential complications included polymorphic ventricular
tachycardia in patients who already had a predisposing factor
for polymorphic ventricular tachycardia and possibly sudden
death.
Among the patients who did not have recurrence of an
uncontrolled ventricular rate within the first 3 months after the
procedure, the ventricular rates during atrial fibrillation at rest
and during mild exertion remained stable for up to 2 years of
follow-up. Although the maximal ventricular rate during exer-
cise increased mildly after 3 months of follow-up, a highly
significant reduction in peak rate relative to baseline was
maintained for up to 2 years. The significant improvement in
symptoms and functional class that accompanied the long-term
control of ventricular rate was comparable in magnitude to the
symptomatic improvement that occurs after AV junction ab-
lation and pacemaker implantation. In some patients, long-
term control of the ventricular rate was accompanied by an
increase in left ventricular ejection fraction, and the improve-
ment in left ventricular function was sometimes dramatic,
particularly in patients with dilated cardiomyopathy that was
apparently idiopathic.
Atrioventricular block. The incidence of high degree AV
block occurring as a complication of the radiofrequency mod-
ification procedure was 16%. Because all the patients in this
study also were appropriate candidates for AV node ablation,
and because the clinical response to AV junction ablation and
pacemaker implantation in patients with atrial fibrillation and
an uncontrolled ventricular rate is usually excellent, a relatively
high risk of AV block did not serve as a deterrent to the
modification procedure. However, the 16% incidence of AV
block indicates that an attempt at radiofrequency modification
may be inappropriate in patients who are not symptomatic
enough to warrant AV node ablation or in patients who find
the possibility of pacemaker implantation unacceptable.
Almost 50% of the cases of inadvertent AV block occurred
on a delayed basis, 36 to 72 h after the procedure. As was the
Figure 5. Left ventricular ejection fraction before and 1 year after
radiofrequency modification of the AV node in 17 patients who had a
successful outcome and in whom the baseline ejection fraction was
,0.50. Solid lines 5 four patients with idiopathic dilated cardiomyop-
athy; dashed lines 5 patients with other types of heart disease. Also
shown is the mean 6 SD at baseline and at 1 year of follow-up (p ,
0.001).
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case in an earlier report (3), the occurrence of transient high
degree AV block during the radiofrequency modification
procedure was a predictor of delayed, persistent AV block, and
the delayed onset of AV block was never observed in patients
who did not develop transient AV block during the procedure.
Therefore, although it is possible that the procedure could be
performed safely on an outpatient basis in some patients, up to
72 h of inpatient ECG monitoring is appropriate if transient
AV block occurs during the radiofrequency modification pro-
cedure.
Relief of symptoms. Ablation of the AV node and insertion
of a permanent pacemaker usually results in a major improve-
ment in symptoms related to atrial fibrillation and an uncon-
trolled ventricular rate (9,10). This has been found in previous
studies and was also the case among the patients in the present
study who required a pacemaker after AV block was induced
either unintentionally or intentionally. Whereas ablation and
pacemaker implantation result in both control and regulariza-
tion of the ventricular rate, the ventricular rate is controlled
but still irregular after the modification procedure. Neverthe-
less, the patients in this study who had a successful outcome
from the standpoint of rate control also had an excellent
clinical response, with as much improvement in symptoms as
the patients who required a pacemaker. However, an attempt
was made to screen out patients whose symptoms were attrib-
utable to irregularity and not rapidity of the ventricular rate.
Left ventricular function. Tachycardia-induced cardiomy-
opathy is a well recognized entity that has been demonstrated
to be at least partially reversible after radiofrequency ablation
of incessant tachycardia or after control of the ventricular rate
by either pharmacologic therapy or by AV node ablation and
pacemaker insertion in patients with atrial fibrillation (11–21).
The results of the present study demonstrate that significant
improvement in left ventricular ejection fraction also may
occur after radiofrequency modification of the AV node in
patients with atrial fibrillation. Although an improvement in
left ventricular ejection fraction was not limited to patients
with a particular type of heart disease, the improvement was
especially notable in patients with dilated cardiomyopathy. In
some of these patients, a markedly abnormal left ventricular
ejection fraction became normalized by 1 year after the
modification procedure, suggesting that the idiopathic dilated
cardiomyopathy was actually a reversible tachycardia-induced
cardiomyopathy. However, the possibility that an improvement
in ejection fraction was spontaneous or related to changes in
drug therapy cannot be ruled out.
Left ventricular ejection fraction may improve after control
of the ventricular rate in patients with atrial fibrillation because
of either a change in loading conditions or intrinsic myocardial
contractility. The simple measurements of left ventricular
ejection fraction obtained in this study do not allow differen-
tiation of whether the improvement was due only to a change
in or was independent of loading conditions. A recent study
(22) demonstrated that in young patients with chronic tachy-
cardia, an improvement in myocardial function after ablation
of the tachycardia is attributable to an increase in contractility,
independent of cardiac loading conditions. Whether these
findings apply to atrial fibrillation with an uncontrolled rate
remains to be determined.
Polymorphic ventricular tachycardia. The incidence of
polymorphic ventricular tachycardia after radiofrequency
modification of the AV node in this study was 3%. In both
patients who experienced this complication, there was an
underlying predisposing factor, either amiodarone-induced
proarrhythmia or hypokalemia (23,24). Both patients displayed
QT prolongation before the episodes of ventricular tachycar-
dia, and in both, the ventricular tachycardia was consistent with
torsade de pointes. Because this type of arrhythmia may be
suppressed by an increase in rate and facilitated by a decrease
in rate (25,26), it is likely that the relative bradycardia that
ensued after the radiofrequency modification procedure was
an aggravating factor, even though the average rate of 70
beats/min at the time of polymorphic ventricular tachycardia
was not excessively slow in absolute terms.
The occurrence of polymorphic ventricular tachycardia in
the two patients in this study indicates that it may be appro-
priate to implant a permanent pacemaker after radiofrequency
modification of the AV node, even in the absence of high
degree AV block, in patients who have QT prolongation or a
predisposition to polymorphic ventricular tachycardia. A pace-
maker allows maintenance of a minimal rate of 80 to 90
beats/min, which may be sufficient to prevent episodes of
torsade de pointes (26,27).
Sudden death. Two patients in this study died suddenly,
one after an apparently successful radiofrequency modification
procedure and the other after AV node ablation and pace-
maker implantation. Both patients had nonischemic cardiomy-
opathy and markedly reduced left ventricular function, a
condition known to be associated with sudden death (28).
Whether sudden death in these patients was related to the
radiofrequency procedure or was a result of the underlying
heart disease is unclear. In the patient whose rate was success-
fully controlled by the modification procedure, the possibility
of bradycardia-facilitated ventricular tachycardia cannot be
ruled out. However, the 2% incidence of sudden death among
the patients in this study who did not require a pacemaker
compares favorably with the incidence of sudden death after
radiofrequency ablation of AV conduction and implantation of
a permanent pacemaker, which has been reported to be as high
as 4% to 6% (29,30). Therefore, even if radiofrequency modi-
fication of the AV node does predispose to sudden death in
some patients, the risk is no higher, and may be lower, than
after AV node ablation and pacemaker implantation.
Comparison with previous studies. The long-term success
rate of 73% in this study is similar to the 70% to 74% success
rate reported in two earlier studies (3,4). However, in two
other studies, the success rate of the radiofrequency modifica-
tion procedure varied widely, from 25 to 85% (5,6). The
number of patients in these previous studies was similar,
ranging from 10 to 20 (3–6). Although the techniques used to
modify AV conduction in those studies were similar in general
terms, there were specific differences, including the rhythm at
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the time of radiofrequency energy delivery, the use of atropine
or isoproterenol during the procedure and the specific end
points of the procedure. Because of these differences, compar-
isons between the success rates of these previous studies may
not be meaningful.
Mechanism of rate control. Some previous studies (2,4,5,31)
have suggested that control of the ventricular rate during atrial
fibrillation results from ablation of the slow pathway or poste-
rior inputs into the AV node. Two findings in the present study
make this possibility unlikely: 1) In the several patients in
whom AV node properties were measurable before and after
the modification procedure, there was a consistent lengthening
of the AH interval and AV block cycle length, effects that are
not observed after slow pathway ablation (32). 2) The inci-
dence of AV block in this study was 16% compared with a
,2% incidence of high degree AV block after slow pathway
ablation (32–36). As previously indicated (3), these findings are
consistent with direct effects on the compact AV node rather
than simply the posterior inputs to the AV node.
Study limitations. A limitation of this study is that patients
were not randomly assigned to undergo modification or abla-
tion of the AV node. Therefore, no definitive conclusions are
possible regarding comparisons of the two procedures relative
to relief of symptoms, improvement in functional class, effects
on left ventricular function or complication rates. A second
limitation is that quality of life was not assessed in a prospec-
tive, systematic fashion using a standardized measurement
instrument.
Conclusions. In ;70% of properly selected patients with
atrial fibrillation and an uncontrolled ventricular rate, radio-
frequency modification of the AV node results in excellent
long-term control of the ventricular rate at rest and during
exertion, relief of symptoms and improvement in functional
class. Furthermore, in some patients with left ventricular
dysfunction, particularly in patients with idiopathic dilated
cardiomyopathy, slowing of the ventricular rate by the modi-
fication procedure may be associated with marked improve-
ment in ejection fraction. Compared with radiofrequency
ablation of the AV node and pacemaker insertion, the princi-
pal drawbacks of the modification procedure are a recurrence
rate of 10% (vs. 0% to 5% after ablation [30,37]) and
facilitation of polymorphic ventricular tachycardia in patients
who are already predisposed to this arrhythmia. In contrast, an
important advantage of the modification procedure is that, if
successful, it obviates the need for a pacemaker, thereby
eliminating the possibility of pacemaker-related complications
and the short- and long-term costs incurred by lifetime pace-
maker therapy.
Among patients with atrial fibrillation who require non-
pharmacologic therapy, ablation of the AV node and pace-
maker implantation may be more appropriate than AV node
modification in patients whose symptoms of palpitations occur
when the ventricular rate is controlled, in patients who may
have a predisposition to polymorphic ventricular tachycardia
and in patients who require or who already have a pacemaker
because of bradyarrhythmia. In other patients with atrial
fibrillation and a rapid ventricular rate, an attempt at radio-
frequency modification of the AV node appears to be an
appropriate alternative to complete ablation of AV conduc-
tion.
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